Ratings Orion S.A.

Equities

OEC

LU1092234845

Specialty Chemicals

Market Closed - Nyse Other stock markets 16:00:02 2025-07-14 EDT			5-day change	1st Jan Change
11.19 ^USD	-0.44%		+3.90%	-29.13%

07-11	DIARY-Nordic corporate earnings week ahead	RE
07-09	Orion Upgrades FY25 Net Sales, Operating Profit Outlook	MT

Summary: Orion S.A.

The company presents an interesting fundamental situation from a short-term investment perspective.

Highlights: Orion S.A.

The company's earnings per share (EPS) are expected to grow significantly over the next few years according to the consensus of analysts covering the stock.
Its low valuation, with P/E ratio at 10.27 and 6.51 for the ongoing fiscal year and 2026 respectively, makes the stock pretty attractive with regard to earnings multiples.
The company has attractive valuation levels with a low EV/sales ratio compared with its peers.
Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
Over the past twelve months, analysts' opinions have been strongly revised upwards.
Predictions on business development from analysts polled by Standard & Poor's are tight. This results from either a good visibility into core activities or accurate earnings releases.

Weaknesses: Orion S.A.

As estimated by analysts, this group is among those businesses with the lowest growth prospects.
The company does not generate enough profits, which is an alarming weak point.
The company is in debt and has limited leeway for investment
The firm pays small or no dividend to shareholders. For that reason, it is not a yield company.
For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
For the last four months, the sales outlook for the coming years has been revised downwards. No recovery of the group's activities is yet foreseen.
For the past year, analysts have significantly revised downwards their profit estimates.
For the last four months, earnings estimated by analysts have been revised downwards with respect to the next two years.
The average price target of analysts who are interested in the stock has been significantly revised downwards over the last four months.
The price targets of analysts who cover the stock differ significantly. This implies difficulties in evaluating the company and its business.

Ratings Chart: Orion S.A.

Source: Surperformance

ESG chart: Orion S.A.

Source: MSCI

Sector Comparison:

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Fundamentals (Composite)	Global Valuation (Composite)	Financial estimates revisions (Composite)	Capi.($)
	ORION S.A.				632M
	ECOLAB INC.				75.69B
	GIVAUDAN SA				43.9B
	SIKA AG				41.5B
	FUJIFILM HOLDINGS CORPORATION				24.59B
	EMS-CHEMIE HOLDING AG				18.9B
	SYMRISE AG				14.66B
	NITTO DENKO CORPORATION				13.19B
	SOCIEDAD QUÍMICA Y MINERA DE CHILE S.A.				10.75B
	EVONIK INDUSTRIES AG				9.78B
	Average				25.36B
	Weighted average by Cap.

See all sector ratings

Investor (Composite)

Trader (Composite)

ESG MSCI

Financials

Revenue growth

EPS growth

Capital Efficiency (Composite)

Net Margin

Financial Health (Composite)

Valuation

P/E

EV/Revenue

EV/EBITDA

PBR

Dividend Yield

Revisions

Revenue revisions (1 year)

Revenue revisions (4 months)

Revenue revisions (1 month)

EPS revisions (1 year)

EPS revisions (4 months)

Consensus

Analysts' buy/sell recommendations

Analysts' recommendations evolution (4 months)

Analysts' target price

Analysts' target price evolution (4 months)

Analysts' target price evolution (1 year)

Business Predictability

Surprise rates

Analysts' coverage

Analysts' recommendations divergence

Analysts' Target price divergence

Financial estimates divergence

ESG

Environment

Social

Governance

Controversy

Ethical controversies

Human rights controversies

Tax subsidies controversies

Sharia compliant

Technical analysis

ST Timing

MT Timing

LT Timing

RSI

Bollinger Spread

Unusual volumes